The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cytokinetics Inc shares valued at $91,960 were sold by Malik Fady Ibraham on Feb 18 ’25. At $45.98 per share, Malik Fady Ibraham sold 2,000 shares. The insider’s holdings dropped to 116,071 shares worth approximately $5.51 million following the completion of this transaction.
Also, Malik Fady Ibraham sold 2,000 shares, netting a total of over 96,120 in proceeds. Following the sale of shares at $48.06 each, the insider now holds 116,071 shares.
Before that, Malik Fady Ibraham had sold 2,000 shares from its account. In a trade valued at $91,840, the EVP Research & Development traded Cytokinetics Inc shares for $45.92 each. Upon closing the transaction, the insider’s holdings decreased to 2,000 shares, worth approximately $5.51 million.
As published in their initiating research note from Citigroup on February 07, 2025, Cytokinetics Inc [CYTK] has been a Buy and the price target has been revised to $86. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in late January. As of November 08, 2024, RBC Capital Mkts has initiated its “an Outperform” rating for CYTK. Earlier on August 13, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for CYTK stock which previously was a “a Buy”.
Analyzing CYTK Stock Performance
During the last five days, there has been a drop of approximately -7.18%. Over the course of the year, Cytokinetics Inc shares have jumped approximately 0.87%. Shares of the company reached a 52-week high of $52.80 on 01/27/25 and a 52-week low of $40.53 on 02/12/25. A 50-day SMA is recorded $47.35, while a 200-day SMA reached $52.58.
Support And Resistance Levels for Cytokinetics Inc (CYTK)
According to the 24-hour chart, there is a support level at 46.73, which, if violated, would cause prices to drop to 46.00. In the upper region, resistance lies at 48.36. The next price resistance is at 49.26. RSI (Relative Strength Index) is 51.11 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.36, which suggests the price will increase in the coming days. Percent R is at 38.27%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
